(Q51380246)

4 April 2018

title

Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes. (English)

1 reference

4 April 2018

0 references

W Yu

1

1 reference

4 April 2018

C Hu

2

1 reference

4 April 2018

R Zhang

3

1 reference

4 April 2018

C Wang

4

1 reference

4 April 2018

W Qin

5

1 reference

4 April 2018

J Lu

6

1 reference

4 April 2018

F Jiang

7

1 reference

4 April 2018

S Tang

8

1 reference

4 April 2018

Y Bao

9

1 reference

4 April 2018

K Xiang

10

1 reference

4 April 2018

W Jia

11

1 reference

4 April 2018

language of work or name

English

0 references

publication date

2 February 2011

1 reference

4 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

4 April 2018

volume

89

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

437-442

1 reference

4 April 2018

Type 2 diabetes: principles of pathogenesis and therapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Insulinotropic meglitinide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Repaglinide versus nateglinide monotherapy: a randomized, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

KCNQ1 gain-of-function mutation in familial atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Thiazolidinediones and the preservation of beta-cell function, cellular proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

A note on exact tests of Hardy-Weinberg equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

inferred from DOI database lookup

7 January 2021

based on heuristic

Skeletal muscle involvement in congenital long QT syndrome

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.351

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.351

1 reference

4 April 2018

1 reference

4 April 2018